MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

NCT06541249 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Polycythemia Vera (PV)
Essential Thrombocythemia (ET)
Myelofibrosis (MF)

Interventions

DRUG: Methotrexate (MTX)

Sponsor

Icahn School of Medicine at Mount Sinai